Close Menu

NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market today that its third quarter revenues were up seven percent year over year.

For the three months ended Sept. 30, NanoString's revenues were $30.6 million compared to $28.6 million in Q3 2018, beating the Wall Street estimate of $28.1 million.

The firm said it took in $26.3 million in product and service revenue in the quarter, a 23 percent increase from $21.5 million in Q3 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.